KaydedilenlerDerginizi ekleyin

Dergiler / Anadolu Kardiyoloji Dergisi / 2008 / Cilt: 8 - Sayı: 1

Kombine heterozigot faktör V Leiden mutasyonu ve antikardiyolipin antikor pozitifliği olan genç bir hastada derin ven trombozu

Combined heterozygote factor V Leiden mutation and anticardiolipin antibody positivity in a young patient with spontaneous deep vein thrombosis

Nuri KARADURMUŞ
Cengiz ÖZTÜRK
Teoman DOĞRU
Alper SÖNMEZ
Selahattin ERİKÇİ
Cantürk TAŞÇI
Satılmış İNAL
Ahmet ÖZTÜRK
Sayfa
71–73
Yayın Tarihi
2022-10-10
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

KARADURMUŞ, N., ÖZTÜRK, C., DOĞRU, T., SÖNMEZ, A., ERİKÇİ, S., TAŞÇI, C., İNAL, S., ÖZTÜRK, A. (2022). Kombine heterozigot faktör V Leiden mutasyonu ve antikardiyolipin antikor pozitifliği olan genç bir hastada derin ven trombozu. Anadolu Kardiyoloji Dergisi, Cilt: 8 - Sayı: 1, 71–73. https://ajindex.com/articles/437088

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Nicolaes GA, Dahlback B. Activated protein C resistance (Factor V Leiden) and thrombosis: factor V mutations causing hypercoagulable states. Hematol Oncol Clin North Am 2003;17: 37-61
  2. Price DT, Ridker PM. Factor V Leiden mutation and the risk for thromboembolic disease: a clinical perspective. Ann Intern Med 1997; 127: 895-903
  3. Lensen RP, Rosendaal FR, Koster T, Allaart CF, de Ronde H, Bertina RM. Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients. Blood 1996; 88: 4205-8
  4. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994; 84: 1031-5
  5. Koeleman BPC, van Rumpt D, Hamulyak K, Reitsma PH, Bertina RM. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families? Thromb Haemost 1995; 74: 580-3
  6. Lensen RPM, Bertina RM, de Ronde H, Vandenbroucke JP, Rosendaal FR. Venous thrombotic risk in family members of unselected individuals with factor V Leiden. Thromb Haemost 2000; 83: 817-21
  7. Lopez FF, Sweeney JD, Blair AJ, Sikov WM. Spontaneous venous thrombosis in a young patient with combined factor V Leiden and lupus anticoagulant. Am J Hematol 1999; 62: 58-60
  8. Wahl DG, Guillemin F, de Maistre E, Perret-Guillaume C, Lecompte T, Thibaut G. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus 1998; 7: 15-22
  9. Bili A, Moss AJ, Francis CW, Zareba W, Watelet LF, Sanz I. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators. Circulation 2000; 102: 1258-63
  10. Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997; 89: 2817-21.